What happened to the prediction of 12-16 weeks since submission, CE mark will be achieved??? It must be week 20+ now.
What sort of time frame are we looking at here?
If the product even marginally improves outcomes for pancreatic cancer patients (which it has shown), shouldn't we expect CE to be granted rather quickly? How does this sort of thing work....
Ann: Appendix 3B, page-16
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.78M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $116.5K | 16.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 12312335 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3137908 | 9 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |